VIVEbiotech Begins a Global Week of Cell and Gene Therapy Engagement Tomorrow
Starting April 28, the company will participate simultaneously in two major international industry events across Europe and Asia.
Starting tomorrow, April 28, VIVEbiotech will be present at two major international cell and gene therapy events, marking an intensive week of global engagement and strategic dialogue across two continents.
In Europe, the company will take part in the Cell & Gene Meeting on the Med, organized by the Alliance for Regenerative Medicine, taking place at the Rome Cavalieri, A Waldorf Astoria Hotel, in Rome, Italy. VIVEbiotech will be represented by Patricio Massera, President & Board Member, and Jon Alberdi, CEO, who will hold meetings with industry leaders, partners, and stakeholders from the advanced therapies ecosystem.
At the same time, starting tomorrow, VIVEbiotech will be exhibiting at BIO KOREA in Seoul, South Korea, at Booth L6. The company’s participation will be led by Natalia Elizalde, Chief Business Development Officer, and Víctor Polo, Business Development Manager, focusing on collaboration opportunities and business development initiatives in the Asia‑Pacific region.
Across both events, VIVEbiotech will be present to discuss its lentiviral vector platform for ex vivo and in vivo gene therapy programs, from early development to GMP manufacturing, and to engage in strategic conversations with key stakeholders in the cell and gene therapy field.
Meeting requests can still be scheduled through the official event partnering platforms or, if not, by contacting us directly via the form available on the VIVEbiotech website.
- Cell & Gene Meeting on the Med: https://informaconnect.com/cell-gene-meeting-on-the-mediterranean/pone/login/
- BIO KOREA: https://www.biokorea.org/en/sso/form.do?key=2404190001